Tim P. Somervaille
550 Wilmslow Road
Manchester, ENG, United Kingdom
Manchester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 69 publications
Real-world treatment patterns and outcomes in accelerated and blast-phase myeloproliferative neoplasms: Insights from a large multi-centre cohort analysis in the United Kingdom.
Journal: British journal of haematology
Published: February 25, 2026
Bleeding Complications in JAK2-Variant Essential Thrombocythemia: A Revisit in 2025.
Journal: EJHaem
Published: May 28, 2025
Retinal determination network reactivation drives chemoresistance and blocks myeloid differentiation in acute myeloid leukemia.
Journal: Cell reports
Published: March 03, 2025
Multi-omic analysis of chronic myelomonocytic leukemia monocytes reveals metabolic and immune dysregulation leading to altered macrophage polarization.
Journal: Leukemia
Published: August 07, 2024
Conserved role of FOXC1 in TNBC is parallel to FOXA1 in ER+ breast cancer.
Journal: iScience
Published: March 22, 2024
Iadademstat in combination with azacitidine in patients with newly diagnosed acute myeloid leukaemia (ALICE): an open-label, phase 2a dose-finding study.
Journal: The Lancet. Haematology
Published: March 15, 2024
An integrative multiparametric approach stratifies putative distinct phenotypes of blast phase chronic myelomonocytic leukemia.
Journal: Cell reports. Medicine
Published: January 18, 2024
A TIAM1-TRIM28 complex mediates epigenetic silencing of protocadherins to promote migration of lung cancer cells.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 25, 2023
Last Updated: 09/26/2026